IOL Chemicals — 360° view

IOL Chemicals, a company in the Pharmaceuticals industry, reported revenue of ₹795 crore and net profit of ₹65 crore for the September 2026 quarter.

IOL Chemicals (NSE: IOLCP) closed at ₹184.12 on 20 Nov 2026, up 101.0% over the past year. Its market capitalisation is ₹5,404 crore and it trades at 25.5 times earnings.

Share price
₹184.12 (20 Nov 2026)
Market cap
₹5,404 Cr (20 Nov 2026)
P/E
25.53 (20 Nov 2026)
Revenue
₹795 Cr (September 2026 quarter)
Net profit
₹65 Cr (September 2026 quarter)
ROCE
11.3% (FY26)
ROE
8.42% (FY26)
Book value
₹65.6 (FY26)
Dividend yield
0.54% (last 12 months to 20 Nov 2026)
52-week high / low
₹224.00 / ₹67.19 (20 Nov 2026)
1-year return
101.0% (to 20 Nov 2026)
Sector
Healthcare
Industry
Pharmaceuticals
Symbol
NSE: IOLCP

IOL Chemicals & Pharmaceuticals Ltd is a leading pharmaceutical (APIs) company and is a significant player in the specialty chemicals space. It serves the domestic and export market. It is the largest player of Ibuprofen (pain killer) globally with a world market share of 35%.

Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.